In this application, we request extension of MERIT award R37MH057881, ?Genetic Association in Schizophrenia and Other Disorders?. In our previous aims, covering the last twenty years, we targeted the development of statistical methods for identifying genetic variants affecting liability to mental disorders. At each cycle we introduced novel statistical methods and evaluated existing methods to extract association signal from genetic data. Here we propose to push the field forward again, but with a different goal in mind: we plan to develop methods to understand how genetic variation influences risk for mental disorders, what neurobiological mechanisms are perturbed, and how such variation can be used to predict those at risk. Because we believe that a large portion of risk to mental disorders is due to perturbation of gene expression and coexpression networks in specific cell types, our first aim will be to develop models to describe tissue?level and cell?level transcriptomes and how they differ by case?control status. Next, we hypothesize that neurobiological mechanisms of risk can best be identified by studying ?community?level? behavior, which could be at the level of coexpressed risk genes or case? control differences in neural circuits connecting brain regions. Thus, in Aim 2, we will develop methods to detect communities in static or dynamic systems and relate them to case?control status. Finally we believe a key to prevention of mental disorders is to first identifying those at risk.
In Aim 3, we will develop methods for prediction of risk that account for fine?scale ancestry and relatedness on the genomic level. We expect that Aims 1?2 will yield key insights into the etiology of mental disorders by modeling core features that determine risk from the genetic and neurobiological perspectives, while Aim 3 lays a foundation for prevention by improving prediction of those at risk. As has been true for our last four funding periods, our theoretical work will be guided by real data from the evolving field of human genetics and transcriptomics. We are well positioned to move between theory and data because we have a diverse team of investigators lead by the PI (Devlin) and subcontract PI (Roeder) who have decades of experience in the statistical genetics field. 4 What individuals will work on the project? Effort (monts) 3.6 2.4 1 6 1 6 Role PI Co?investigator Co?investigator Technician Technician Technician Degree PhD PhD PhD PhD PhD PhD DOB 10/1954 03/1959 11/1982 SSN 2807 1876 6455 Name Devlin, Bernie Roeder, Kathryn Lei, Jing Klei, Lambertus Doman, John TBH Post?Doc Key Yes Yes Yes No No No Commons ID devlinbj roeder jinglei 5

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH057881-22
Application #
9750799
Study Section
Special Emphasis Panel (NSS)
Program Officer
Gitik, Miri
Project Start
1998-07-01
Project End
2023-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
22
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Huckins, L M; Hatzikotoulas, K; Southam, L et al. (2018) Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 23:1169-1180
Wang, Daifeng; Liu, Shuang; Warrell, Jonathan et al. (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science 362:
Yip, Benjamin Hon Kei; Bai, Dan; Mahjani, Behrang et al. (2018) Heritable Variation, With Little or No Maternal Effect, Accounts for Recurrence Risk to Autism Spectrum Disorder in Sweden. Biol Psychiatry 83:589-597
Mitchell, A C; Javidfar, B; Pothula, V et al. (2018) MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry 23:123-132
Bryois, Julien; Garrett, Melanie E; Song, Lingyun et al. (2018) Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. Nat Commun 9:3121
Fazio, Leonardo; Pergola, Giulio; Papalino, Marco et al. (2018) Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc Natl Acad Sci U S A 115:5582-5587
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
An, Joon-Yong; Lin, Kevin; Zhu, Lingxue et al. (2018) Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science 362:
Gandal, Michael J; Zhang, Pan; Hadjimichael, Evi et al. (2018) Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science 362:
Girdhar, Kiran; Hoffman, Gabriel E; Jiang, Yan et al. (2018) Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome. Nat Neurosci 21:1126-1136

Showing the most recent 10 out of 72 publications